Philips CPAP machines have been recalled because foam used in them can be inhaled by users and emit toxic gases. Users who inhale the foam or the gases emitted by the foam may develop numerous health effects, including numerous cancers.
Lawsuits allege that Philips knew about this problem well before they recalled the units, yet failed to warn users about the problem.
Call us today for a free consultation or text us from this page if you or a loved one became ill after using a Philips CPAP device. You may qualify for financial compensation. We won’t charge you a fee to handle your CPAP lawsuit until and unless we win your case.
2023 Philips CPAP Lawsuit Update & Latest News
April 2023
Philips announced it had set aside $630 million to resolve economic loss claims regarding its recalled CPAP devices.
March 2023
Royal Philips CEO Roy Jakobs stated that Philips is close to settling CPAP class action lawsuits, and that the settlements may be finalized some time in 2023. Jakobs stated the company hopes they can settle personal injury lawsuits after that, perhaps in 2024.
February 2023
Philips recalled some Philips Dreamstations which had been reworked because, in the process of giving the devices their initial programming, some devices were assigned duplicate or incorrect serial numbers. This could lead to therapy failure or incorrect failure, which could lead to serious injury or death.
The FDA reported that almost 350 deaths have been linked with Philips’ recalled CPAP devices.
January 2023
Plaintiffs in the CPAP multidistrict litigation called for the first CPAP bellwether trial to take place in summer 2024. Defendants called for the first bellwether trial to take place in 2026.
December 2022
Philips recalled four BiPAP machines because the plastic in them may be contaminated with material which could cause volatile organic compounds to be released. The recalled models are: OmniLab Advanced+, A-Series BiPAP V30, A-Series BiPAP A40 and A-Series BiPAP A30.
November 2022
On November 17, 2022, Philips told the FDA that reworked Philips Respironics Trilogy ventilators involved in the June 2021 recall have two new possible issues:
- The new sound abatement foam might separate from its plastic backing, blocking the air inlet and lowering the air pressure
- Particulate matter has been found in some reworked ventilators’ air pathways
Then, on November 22, 2022, the FDA provided information about medical device reports they received between August 1 and October 31, 2022. The FDA reported that, during this time span, they received over 21,000 medical device reports involving foam breakdown in CPAP machines, BiPAP machines and ventilators, including 91 reports of deaths.
September 2022
Philips recalled over 17 million masks for BiPAP and CPAP units because of magnets in them which may cause serious injury or death by interfering with metallic objects in the body. Click here for more information.